Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Market Cap
$159.80M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$159.14M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$162.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$156.22M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
Market Cap
$165.32M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
2.28x
5Y Avg
2.28x
Market Cap
$153.79M
Interest Coverage Ratio
-3.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $159.78M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -5.64x | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | -19.95x | 6.75x | 6.75x | 6.75x |
| Quanterix Corporation (QTRX)vs › | $162.04M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.22M | N/A | 2247.41x | 1131.54x | 905.57x |
| Nkarta, Inc. (NKTX)vs › | $165.27M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 2.28x | 2.28x | 2.28x | 2.28x |
| Neuronetics, Inc. (STIM)vs › | $153.79M | -3.74x | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | -1.03x | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.13
Current Ratio
13.36
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
